The IQIsolate technology represents a breakthrough in helping providers confirm suspected diagnoses of complex autoimmune diseases and related conditions.
Whether you are seeing a patient who presents with symptoms for the first time or treating a patient following a referral, IQuity’s technology gives you information to confirm a suspected diagnosis, determine any additional diagnostic work-up needed, and initiate treatment at the earliest onset of the disease.
Internists & Primary Care
Primary Care and Internal Medicine providers are often the first to see patients who present with a suspected autoimmune disease or related condition.
When you suspect that a patient’s symptoms may indicate an autoimmune disease or related condition like multiple sclerosis, IBS, Crohn's, ulcerative colitis, rheumatoid arthritis, lupus or fibromyalgia, IQuity’s breakthrough RNA technology, IQIsolate, powers test panels that provide a Yes or No result in as little as 7 days (conventional testing processes often can take months to years to confirm a diagnosis).
Now referrals to specialists can be accompanied with a test result that is more than 90% accurate.